Programme overview
The field of cancer genomics and recent technological advances are shaping how we diagnose and treat cancer. This virtual course will teach the core concepts of risk stratification using family history as a tool to enable patients to access appropriate management strategies.
Course aims
The course is designed for all healthcare professionals working in primary care and specialist settings including oncology, breast care, gynae-oncology, gastroenterology and screening services. Participants will be equipped with the basics of cancer genetic counselling and sessions will include approaches to genetic testing, management of hereditary cancers and consent taking.
TBC CPD points
Awarded by Nucleus
Who should attend
This course is designed for all healthcare professionals working in primary care and specialist settings including oncology, breast care, gynae-oncology, gastroenterology and screening services.
Format
This course pass includes e learning:
- Access to Nucleus where you will complete compulsory self-study day either on the 23rd of April 2024 or in your own time before the 13th May 2024.
- Six half day didactic morning sessions on Zoom. Dates for the six sessions are below:
- Monday, 13th May 2024
- Tuesday, 14th May 2024
- Monday, 10th June 2024
- Tuesday, 11th June 2024
- Monday, 8th July 2024
- Tuesday, 9th July 2024
Your fee includes the course package ‘Cancer Genomics: The Essentials’ which is hosted online via Nucleus. Upon purchasing your pass you will receive your Nucleus login within 48 hours. The course teaches the key concepts every health practitioner needs to know about cancer genomics. It consists of four modules that cover the basic principles of cancer genomics, ranging from cancer biology to hereditary cancer risk assessment to the utility of precision oncology in cancer treatment. It provides users with a solid understanding of these fundamental concepts and how to apply this knowledge to daily clinical practice. Additionally, as genomics becomes universally applied in healthcare, many questions will naturally arise. You will also be able to join our online Slack community via Nucleus to have direct contact with the content developers, as well as other like-minded healthcare professionals.
Upon complete of the course delegates will receive a certificate of attendance
(Please note these sessions will not be repeated nor will they be recorded)
Draft agenda
How to book
Course Directors
Dr Vishakha Tripathi
Consultant Genetic Counsellor
Vishakha Tripathi is a registered genetic counsellor and past chair of the Genetic Counsellor Registration Board (GCRB). She is also a professional member of the Academy for Healthcare Science (AHCS). She has worked in genetic counselling for 20 years. She currently leads the genetic counselling team, the HBOC family service and the Cancer Risk Assessment and family history services. Vishakha is part of the Clinical Genetics operational team and senior leadership team. She is also a member on to the Genomics Clinical Reference Group within NHS England. Her specialist interests include service development, clinical pathway transformation, healthcare education and the use of advanced psychosocial skills in genetic counselling. She delivers and leads the cancer genetics course for healthcare professionals with colleagues from King’s College London.
Anjana Kulkarni
Consultant Clinical Geneticist and Lead for Cancer Genetics service, GSTT
Anjana Kulkarni was appointed as a consultant in cancer and clinical genetics at Guy’s hospital in 2012. She trained at specialist level in both Medical Oncology and Clinical Genetics, giving her an in-depth knowledge of genomics and translational medicine within cancer care. Dr Kulkarni holds several national roles, including council member of the UK Cancer Genetics Group, medical advisor to the UK Genetic Counselling Registration Board and member of the Sarah Cannon Research Institutes’ Genomic Review Board. She has extensive clinical and academic experience in Cancer Genetics and has published, presented and taught on the topic at national and international level. Dr Kulkarni has a track record of establishing policies and guidelines relating to cancer genetics, by working with a broad range of colleagues across genetics and allied specialties. She has been instrumental in the establishment of several digital transformation initiatives, including an internationally recognised Cancer Genetics app for healthcare professionals.